Does Delta-10 THC Show Up on a Drug Test? Hemp Derived Isomers and the THC Screen

Delta-10 THC is a hemp derived cannabinoid isomer sold in vape cartridges, gummies and tinctures, usually marketed as a milder, legal alternative to marijuana. Employers and employees asking whether it shows up on a drug test are really asking two separate questions: will a screening immunoassay flag it, and will a confirmation lab report it as a marijuana metabolite. The short answer is that delta-10 THC and its metabolites can cross react with the same urine immunoassays used to screen for delta-9 THC, and a confirmation test can report a THC-COOH positive. Whether a product is legal to buy under the 2018 Farm Bill has no bearing on whether it produces a positive drug test result.

What delta-10 THC actually is

Delta-10 THC is a minor cannabinoid that occurs in trace amounts in the cannabis plant. Most delta-10 sold commercially is produced by chemically converting CBD extracted from hemp, the same starting process used to make delta-8 THC. The Agriculture Improvement Act of 2018, commonly called the Farm Bill, legalized hemp and hemp derived cannabinoids at the federal level only when the finished product contains no more than 0.3 percent delta-9 THC by dry weight. The Drug Enforcement Administration addressed how this definition applies to hemp derived and synthetically modified cannabinoids in its interim final rule implementing the Farm Bill, which remains the government's primary statement on where hemp processing can cross into controlled substance territory. That rule, published in the Federal Register, is the source to read before assuming any hemp derived isomer is automatically legal in every form. A product's retail legality under that framework says nothing about what a laboratory instrument will detect in a urine specimen.

Screening immunoassays do not distinguish THC isomers well

A standard workplace urine drug test starts with an immunoassay screen, a chemical test that uses antibodies to bind to a target molecule family rather than one single compound. Immunoassays are built to catch delta-9 THC metabolites, but the antibodies used in most cannabinoid screening kits were not designed to exclude closely related isomers. A 2025 laboratory study tested six commercially available homogeneous enzyme immunoassays against delta-8 THC, delta-10 THC, CBD, their metabolites and chiral carboxy HHC metabolites in urine. The study, published on PubMed Central, found that five of the six assays cross reacted with delta-10 THC analogs, generally in the 50 to 100 ng/mL range, while cross reactivity varied by which chiral isomer was present. Unmetabolized CBD itself did not trigger the assays at the concentrations tested, but CBD's own hydroxylated metabolites did. In plain terms, a person using a delta-10 THC vape or edible can produce a presumptive positive screen on most, though not all, of the immunoassay platforms labs commonly use.

Confirmation testing, specimen handling and the honest limits of the science

A presumptive positive immunoassay screen is not a final result. Federal workplace programs and most private employer policies require that any nonnegative screen be confirmed by gas chromatography mass spectrometry (GC/MS) or liquid chromatography tandem mass spectrometry (LC/MS-MS), methods that separate compounds by their physical and chemical properties rather than relying on antibody binding. The Mandatory Guidelines for Federal Workplace Drug Testing Programs, administered by the Substance Abuse and Mental Health Services Administration (SAMHSA) and published in the Federal Register, set the confirmatory target analyte for marijuana as THC-COOH (11-nor-9-carboxy-delta-9-THC) with defined cutoff concentrations. Those Mandatory Guidelines describe the two step screen and confirm process that federally regulated and most employer drug testing programs follow. Because delta-8 THC and delta-10 THC metabolize into carboxylated acid metabolites that closely resemble THC-COOH, a confirmation lab can, depending on the method's specificity and the metabolite panel it targets, report a positive marijuana metabolite result from delta-10 use. There is limited published evidence precisely quantifying how often this happens in real world specimens, and the available cross reactivity data comes from spiked laboratory samples rather than large population studies, so any claim beyond what the cited studies show should be treated as unproven.

Specimen handling also matters and is easy to get wrong when reading about this topic. A companion stability study on the same emerging cannabinoid analogs found that delta-8 THC, delta-10 THC and carboxy-HHC degrade rapidly at higher temperatures and under acidic pH, to the point that a specimen held at elevated temperature for even a single day showed the parent compounds falling below detectable levels. That preanalytical stability research explains why a delayed or poorly stored specimen can sometimes screen negative even when the product was used recently, which cuts against any assumption that these isomers behave identically to delta-9 THC metabolites in every condition. Employers and collection sites should rely on standard chain of custody and temperature controls rather than guessing at how an individual specimen will hold up.

The Farm Bill does not create a drug test exemption

A common misunderstanding is that because a delta-10 THC product is sold legally under the 2018 Farm Bill, a positive drug test result from using it should not count. That is not how workplace drug testing programs work. The Farm Bill's 0.3 percent delta-9 THC by dry weight threshold is a manufacturing and interstate commerce standard; it does not instruct drug testing laboratories or Medical Review Officers to disregard a confirmed THC-COOH result because the source was a hemp derived isomer. For DOT regulated safety sensitive positions, the confirmation and review process is governed separately by 49 CFR Part 40, which sets out the specimen collection, laboratory and Medical Review Officer procedures that apply once a specimen screens nonnegative, and it does not carve out an exception for hemp derived cannabinoids. A DOT covered employee who tests positive after using a delta-10 product is in the same position as one who tested positive after using marijuana; the legal status of the retail product is not a defense recognized in that process.

The Food and Drug Administration has also been clear that it has not approved delta-8, delta-10 or other synthetic or semisynthetic cannabinoid products as foods, supplements or drugs, and has issued warning letters over marketing claims for these products. The FDA's cannabis and cannabis derived products page lists the handful of approved by FDA cannabis based medications and states plainly that no other cannabis or cannabis derived compound has been approved as safe and effective for any use. These are not FDA cleared drug testing products or treatments; this article is describing the regulatory record, not endorsing the compounds themselves.

What a positive result means for the donor

Any nonnegative confirmed laboratory result in a regulated or employer program should route to a Medical Review Officer, a licensed physician trained to interpret test results and review them with the person tested before the result is reported to the employer as positive. The MRO contacts the donor, asks about prescription medications and legitimate medical explanations, and makes the final determination. SAMHSA's Drug-Free Workplace program resources describe this review step and the certified laboratory network that federal and many private programs rely on. SAMHSA's workplace employer resources page is the primary federal reference point for how certified laboratories and drug-free workplace programs are structured. Delta-10 THC use is not a recognized medical exemption in that review, since it is not a prescribed medication; a donor who wants to explain a result should keep any documentation of what product was used and when, and let the MRO process run its course rather than attempting to argue the point informally with an employer. This article does not offer legal advice about how a specific case will be handled, since outcomes depend on the applicable program rules and, for non-DOT employers, on company policy and state law, which varies and should be reviewed with qualified counsel.

Panel and product selection for programs that screen for hemp isomers

Employers building or reviewing a drug testing program should confirm with their laboratory exactly which cannabinoid metabolites a given cup, dip card or oral fluid panel and its confirmation protocol are validated to detect, since not every immunoassay or confirmation method on the market targets the same isomer set. A standard THC panel on a drug test cup is built around delta-9 THC metabolite detection, and the cross reactivity data above shows that detection of delta-8 or delta-10 analogs cannot be assumed uniform across brands or lots. Programs with specific concerns about hemp derived isomer use should ask their reference laboratory about confirmation testing scope rather than relying on the screening cup alone. For background on how other hemp derived isomers behave on a THC screen, see our related coverage of delta-8 THC and drug testing and HHC and drug testing.

Frequently asked questions

Does delta-10 THC show up as a positive on a standard THC drug test?

It can. Laboratory testing has found that most, though not all, commercial urine immunoassay screening kits cross react with delta-10 THC and its metabolites, which can produce a presumptive positive result that then goes to confirmation testing.

Is delta-10 THC legal, and does that stop a positive result from counting?

Products meeting the Farm Bill's 0.3 percent delta-9 THC by dry weight threshold can be sold legally at the federal level, but that manufacturing standard does not instruct drug testing laboratories or Medical Review Officers to disregard a confirmed THC-COOH result. Legality of the product and the outcome of a drug test are separate questions.

Will confirmation testing tell delta-10 THC apart from marijuana use?

Confirmation by GC/MS or LC/MS-MS targets THC-COOH and related metabolites at a defined cutoff. Because delta-8 and delta-10 THC metabolize into carboxylated acids that resemble THC-COOH, confirmation can report a positive marijuana metabolite result; whether it specifically identifies the source as a hemp isomer depends on the laboratory's method and analyte scope.

What happens after a positive screen in a DOT regulated job?

The specimen is confirmed at a certified laboratory and then reviewed by a Medical Review Officer under the procedures in 49 CFR Part 40 before any result is reported to the employer. Hemp product use is not a recognized medical exemption in that review.

Can specimen handling affect whether delta-10 THC is detected?

Yes. Published stability research found that delta-8 THC, delta-10 THC and related carboxy-HHC metabolites can degrade quickly in urine at elevated temperature or acidic pH, which can reduce detectable levels if a specimen is not promptly refrigerated and properly transported.

Should an employer try to write a policy specifically targeting delta-10 THC?

Employers generally may address hemp derived cannabinoid use in a drug-free workplace policy, but policy design, state law and any accommodation questions vary and should be reviewed with qualified counsel rather than decided from general information like this article.

This article is general information for employers and screening program administrators, not legal or medical advice. Testing policies, confirmation methods and legal requirements vary by program and jurisdiction; consult qualified counsel and your laboratory's Medical Review Officer for case specific guidance.